compounding tirzepatide / Niacinamide – WP Pharma Labs FDA Allows Compounded Tirzepatide During

To view or add a comment, sign in For those who are interested in weight management/obesity therapies, yestetday, the US FDA approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, called Wegovy HD, for weight loss and long-term maintenance of weight loss for certain adult patients

FIGURE 1 Rather than attempting confirmatory quantitative synthesis across all outcomes, we deliberately restricted quantitative analysis to a methodological demonstration

Newer research also shows that for people with less weight to lose, the GLP-1s semaglutide and liraglutide help preserve muscle during weight loss

SGLT2 inhibitors have demonstrated robust reductions in hospitalisation for heart failure across risk groups, with cardiovascular death benefits most clearly established in heart failure trials